A5077424049- Coronary Interventions and Diagnostics
- Pulmonary Hypertension Research and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Vascular Procedures and Complications
- Acute Myocardial Infarction Research
- Venous Thromboembolism Diagnosis and Management
- Peripheral Artery Disease Management
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac and Coronary Surgery Techniques
- Cardiac Imaging and Diagnostics
- Aortic aneurysm repair treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- Renal and Vascular Pathologies
- Cardiovascular Function and Risk Factors
- Radiation Dose and Imaging
- Lipoproteins and Cardiovascular Health
- Vascular Anomalies and Treatments
- Cardiovascular Issues in Pregnancy
- Mechanical Circulatory Support Devices
- Total Knee Arthroplasty Outcomes
- Cardiac Arrest and Resuscitation
- Cardiac Arrhythmias and Treatments
- Orthopaedic implants and arthroplasty
- MRI in cancer diagnosis
University of California, San Diego
2015-2024
UC San Diego Health System
2024
University of California San Diego Medical Center
2008-2023
American Heart Association
2017
American College of Cardiology
2017
Macquarie University
2014
Santa Barbara Cottage Hospital
2013
UCLA Medical Center
2013
Azienda Ospedaliero Universitaria San Giovanni Battista
2013
University of Turin
2013
Elevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation late MACE unknown.Baseline demographics and 2-year were recorded among subjects undergoing nonemergent intervention. A total of 332 (66.6±19.5 years, 69.9% male, 25.3% acute syndrome) enrolled. Two-year (periprocedural myocardial infarction 9.0%, rehospitalization 6.3%, revascularization 12.7%, non-periprocedural 4.5%, stent thrombosis 0.9%,...
Abstract Objectives To assess the long‐term safety and efficacy of robotic percutaneous coronary revascularization for use in complex lesions. Background Robotically assisted intervention (PCI) is safe feasible simple lesions has excellent short‐term procedural clinical outcomes lesions; however, are unknown. Methods A total 103 consecutive patients underwent a 108 (R)‐PCI procedures (age 68.1; 78.3% male) over 18 months, 210 226 manual (M)‐PCI 67.5; 78.1% during same period. Patients were...
We aimed to examine factors impacting variability in cardiac procedural deferral during the COVID-19 pandemic and assess cardiologists' perspectives regarding its implications. Unprecedented was implemented nationwide pandemic. A web-based survey administered by Society for Cardiovascular Angiography Interventions American College of Cardiology Interventional Council catheterization laboratory (CCL) directors interventional cardiologists across United States Among 414 total responses, 48...
Lipoprotein(a; Lp[a]) and its associated oxidized phospholipids are causal, genetic risk factors for calcific aortic valve stenosis (CAVS). We determined the prevalence of Lp(a) measurement among 2710 patients with CAVS 1369 control (∼50% study group) without an echocardiogram between January 2010 February 2016 in academic echocardiography laboratory. Lipoprotein(a) measurements were performed at a referral laboratory using isoform-independent assay. The any was 4.6% (124 2710) 3.1% (42...
Renal artery (RA) stenting can improve control of hypertension yet predicting clinical response remains difficult. We sought to determine the role renal frame count (RFC) (number angiographic frames for contrast reach distal parenchyma after initial RA opacification) as a predictor improvement in blood pressure (BP) stenting.Renal flow was quantified 68 consecutive patients (age 72.5 ± 9.1 years, 72% male) undergoing refractory (BP ≥ 140/90 mm Hg despite treatment with two or more...